Literature DB >> 10801979

Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene.

D A Leib1, M A Machalek, B R Williams, R H Silverman, H W Virgin.   

Abstract

To produce disease, viruses must enter the host, multiply locally in host tissues, spread from the site of entry, and overcome or evade host immune responses. At each stage in this infectious process, specific microbial and host genes determine the ultimate virulence of the virus. Genetic approaches have identified many viral genes that play critical roles in virulence and are presumed to target specific components of the host innate and acquired immune response. However, formal proof that a virulence gene targets a specific protein in a host pathway in vivo has not been obtained. Based on cell culture studies, it has been proposed that the herpes simplex virus type 1 gene ICP34.5 (ICP, infected cell protein) enhances neurovirulence by negating antiviral functions of the IFN-inducible double-stranded RNA-dependent protein kinase R or PKR [Chou, J., Chen, J.J., Gross, M. & Roizman, B. (1995) Proc. Natl. Acad. Sci. USA 92, 10516-10520]. Herein, we show that a virus that has been attenuated by deletion of ICP34.5 exhibits wild-type replication and virulence in a host from which the PKR gene has been deleted. We show that restoration of virulence is specific to ICP34.5 and PKR by using additional host and viral mutants. The use of recombinant viruses to infect animals with null mutations in host defense genes provides a formal genetic test for identifying in vivo mechanisms and targets of microbial virulence genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801979      PMCID: PMC18564          DOI: 10.1073/pnas.100415697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.

Authors:  A Zhou; J Paranjape; T L Brown; H Nie; S Naik; B Dong; A Chang; B Trapp; R Fairchild; C Colmenares; R H Silverman
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

2.  Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.

Authors:  H E Farrell; H Vally; D M Lynch; P Fleming; G R Shellam; A A Scalzo; N J Davis-Poynter
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

3.  Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice.

Authors:  E M Simpson; C C Linder; E E Sargent; M T Davisson; L E Mobraaten; J J Sharp
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation.

Authors:  G C Perng; H Ghiasi; S M Slanina; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture.

Authors:  J Chou; E R Kern; R J Whitley; B Roizman
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

6.  Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control.

Authors:  I Crnković-Mertens; M Messerle; I Milotić; U Szepan; N Kucić; A Krmpotić; S Jonjić; U H Koszinowski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB.

Authors:  A Kumar; Y L Yang; V Flati; S Der; S Kadereit; A Deb; J Haque; L Reis; C Weissmann; B R Williams
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

8.  The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase.

Authors:  B He; M Gross; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

9.  Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response.

Authors:  K Goldsmith; W Chen; D C Johnson; R L Hendricks
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  119 in total

1.  HSV.com: maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense.

Authors:  S L Tan; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.

Authors:  Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Nuclear translocation and activation of the transcription factor NFAT is blocked by herpes simplex virus infection.

Authors:  E S Scott; S Malcomber; P O'Hare
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals.

Authors:  I Mohr; D Sternberg; S Ward; D Leib; M Mulvey; Y Gluzman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

Authors:  T Todo; R L Martuza; S D Rabkin; P A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

6.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

7.  Signals that dictate nuclear, nucleolar, and cytoplasmic shuttling of the gamma(1)34.5 protein of herpes simplex virus type 1.

Authors:  Guofeng Cheng; Marie-Elena Brett; Bin He
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 8.  Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing.

Authors:  Leonid Gitlin; Raul Andino
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway.

Authors:  Daniel J J Carr; Khaldun Al-khatib; Cassandra M James; Robert Silverman
Journal:  J Neuroimmunol       Date:  2003-08       Impact factor: 3.478

10.  Binding and relocalization of protein kinase R by murine cytomegalovirus.

Authors:  Stephanie J Child; Adam P Geballe
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.